Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
09/28/2005 | EP1578721A2 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
09/28/2005 | EP1578423A1 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
09/28/2005 | EP1578413A2 Ace-inhibitors having antioxidant and no-donor activity |
09/28/2005 | EP1463731B1 Dibenzodiazepine derivates, their preparation and use |
09/28/2005 | EP1439849A4 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease |
09/28/2005 | EP1397348B1 Factor xa inhibitor |
09/28/2005 | EP1366029B1 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolins and the utilization thereof as anticoagulant and antithrombotic agents |
09/28/2005 | EP1361880B1 6-substituted pyrido-pyrimidines |
09/28/2005 | EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
09/28/2005 | EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
09/28/2005 | EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors |
09/28/2005 | EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors |
09/28/2005 | EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof |
09/28/2005 | EP1267905B1 Composition for the treatment of heart failure |
09/28/2005 | EP1265838B1 Novel fatty acid analogous |
09/28/2005 | EP1243583B1 Heterocyclic compounds having sulfonamide groups |
09/28/2005 | EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same |
09/28/2005 | EP1210348B1 Naphthyridine derivatives, processes for their preparation, their use and pharmaceutical compositions comprising them |
09/28/2005 | EP1165510B1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
09/28/2005 | EP1093453B1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
09/28/2005 | EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
09/28/2005 | EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues |
09/28/2005 | EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid |
09/28/2005 | CN1675344A Oil or fat composition |
09/28/2005 | CN1675250A Epimerized derivatives of K5 polysaccharide with a very high degree of sulfation |
09/28/2005 | CN1675249A Process for the manufacture of n-acyl-(epi)k5-amine-o-sulfate-derivatives and products thus obtained |
09/28/2005 | CN1675229A Sulfur-containing phospholipid derivatives |
09/28/2005 | CN1675213A 新的嘌呤衍生物 New purine derivatives |
09/28/2005 | CN1675211A 新的嘌呤衍生物 New purine derivatives |
09/28/2005 | CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors |
09/28/2005 | CN1675209A Dihydropyrazolopyridine compounds |
09/28/2005 | CN1675208A Novel fused imidazole derivative |
09/28/2005 | CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same |
09/28/2005 | CN1675205A Novel quinuclidine derivatives and their use |
09/28/2005 | CN1675203A Substituted 1-piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
09/28/2005 | CN1675201A N-substituted piperidine derivatives as serotonin receptor agents |
09/28/2005 | CN1675199A Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
09/28/2005 | CN1675198A Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
09/28/2005 | CN1675171A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
09/28/2005 | CN1675168A Propionic acid derivatives and their use as hPPARs activators |
09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
09/28/2005 | CN1674938A Combination of VEGF receptor tyrosine kinase inhibitors for treatment of cancer |
09/28/2005 | CN1674928A Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
09/28/2005 | CN1674927A Growth hormone releasing peptides |
09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
09/28/2005 | CN1674914A Female hormone-containing patch |
09/28/2005 | CN1674907A Use of reboxetine for the treatment of hot flashes |
09/28/2005 | CN1674900A N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein B secretion |
09/28/2005 | CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators |
09/28/2005 | CN1674895A Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals |
09/28/2005 | CN1674883A Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
09/28/2005 | CN1674881A Drug composition containing NF-kappa B inhibitor |
09/28/2005 | CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
09/28/2005 | CN1673380A Phosphoric acid receptor protein gene glandular related viral vector and construction and application |
09/28/2005 | CN1673220A Deoxyneohydroxyaspergillic acid and its prepn and use |
09/28/2005 | CN1673210A Optical isomer of phencynonate and its use in preparing medicine |
09/28/2005 | CN1672745A Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
09/28/2005 | CN1672726A Life-prolonging Chinese medicine prepn of haw |
09/28/2005 | CN1672712A New recipe and prepn process of blood fat reducing medicine |
09/28/2005 | CN1672699A Medicine for treating phlebothrombosis and thrombotic superficial phlebitis of lower limb and its prepn |
09/28/2005 | CN1672695A Medicine for treating apoplexy and its sequela |
09/28/2005 | CN1672692A Naoxuekang dripping pill and its prepn process |
09/28/2005 | CN1672687A Transfused breviscapine prepn |
09/28/2005 | CN1220768C Variant strain of monoscus purpureus for generating lovastatin with high yield and its application |
09/28/2005 | CN1220699C Polypeptide for inhibiting growth and migration of blood vessel endothelial cell and endothelial stem cell and its preparing method and use |
09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
09/28/2005 | CN1220681C Indole derivatives as XA factor inhibitors |
09/28/2005 | CN1220520C Inhibition of 2, 3-dihydrogen-indone to 26S and 20S prolease |
09/28/2005 | CN1220509C Chinese patent medicine for curing cardiovascular disease, its preparation method and quality control method |
09/28/2005 | CN1220504C Medicine for treating coronary heart disease and preparing method thereof |
09/28/2005 | CN1220497C Antivirus antioxidizing active extract of proplis and its molecular clathrate compound preparation |
09/28/2005 | CN1220489C Freeze-dried Danhong powder injection for injection and its preparing method |
09/28/2005 | CN1220488C Combination of fenofibrate and coenzyme Q10 for the treatment of endothelial dysfunction |
09/28/2005 | CN1220486C Beta -cyclodextrin of veratrum alcohol compound or its clathrate compound of derivative and its preparation |
09/27/2005 | US6949655 Acyclic piperidine derivatives |
09/27/2005 | US6949584 use in inhibiting angiogenesis in a mammal |
09/27/2005 | US6949583 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same |
09/27/2005 | US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders |
09/27/2005 | US6949579 Central nervous system disorders; antidiabetic agents |
09/27/2005 | US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis |
09/27/2005 | US6949575 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoindane derivatives |
09/27/2005 | US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
09/27/2005 | US6949572 Antilipemic or antilipolytic agents for treatment of obesity and lipid disorders, S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide |
09/27/2005 | US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
09/27/2005 | US6949566 For use as metalloproteinase inhibitors |
09/27/2005 | US6949565 Protein kinase inhibitors |
09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
09/27/2005 | US6949555 Use of organic compounds |
09/27/2005 | US6949554 Calcium channel blockers comprising two benzhydril moieties |
09/27/2005 | US6949553 Aliphatic compounds, their synthesis method, and utilization of the same |
09/27/2005 | US6949548 administering a synergistic combination of levosimendan or a pharmaceutically acceptable salt thereof and a beta-adrenergic receptor antagonist to a patient in need of such treatment |
09/27/2005 | US6949547 Antidiabetic agents; central nervous system disorders; cardiovascular disorders; hypotensive agents; anticancer agents |
09/27/2005 | US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
09/27/2005 | US6949538 Compounds, compositions, and methods |